Zhou, Yitian http://orcid.org/0000-0003-3066-5444
Pirmann, Sebastian
Lauschke, Volker M. http://orcid.org/0000-0002-1140-6204
Funding for this research was provided by:
Vetenskapsrådet (2023-03015)
Cancerfonden (23-0763PT)
Article History
Received: 29 February 2024
Revised: 26 April 2024
Accepted: 15 May 2024
First Online: 27 May 2024
Competing interests
: YZ and VML are co-founders and shareholders of Shanghai Hepo Biotechnology Ltd. VML is CEO and shareholder of HepaPredict AB. SP declares no conflicts of interest.
: All data analyzed in this work was extracted from gnomAD, a repository that makes aggregated genomic data publicly available under the Fort Lauderdale Agreement. The contributing studies () were conducted in accordance with the Declaration of Helsinki. Details about the responsible ethics committees can be found in the descriptions of the contributing projects.